SCM
GILD icon

Suvretta Capital Management’s Gilead Sciences GILD Stock Holding History

Suvretta Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-50,700
Closed -$3.48M – 104
2024
Q2 		$3.48M Hold
50,700
– – 0.13% 62
2024
Q1 		$3.71M Buy
50,700
+28,000
+123% +$2.15M 0.14% 68
2023
Q4 		$1.84M Hold
22,700
– – 0.08% 67
2023
Q3 		$1.7M Hold
22,700
– – 0.09% 67
2023
Q2 		$1.75M Hold
22,700
– – 0.09% 77
2023
Q1 		$1.88M Buy
+22,700
New +$1.88M 0.08% 70

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Suvretta Capital Management's GILD Position: Q3 2024 in Review

Suvretta Capital Management sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 50,700 shares — an estimated $3.48M sold.

Suvretta Capital Management first reported a position in GILD in Q1 2023 and held it in 6 quarters. The position peaked at $3.71M in Q1 2024. 1,718 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

  • Suvretta Capital Management reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
  • Suvretta Capital Management sold 50,700 Gilead Sciences shares in Q3 2024, an estimated $3.48M.
  • Suvretta Capital Management first reported a position in Gilead Sciences in Q1 2023 and held it in 6 quarters.
  • Suvretta Capital Management's Gilead Sciences position peaked at $3.71M in Q1 2024.
  • 1,718 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on Suvretta Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.